Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
2022 · Journal of Hepatology · 113 citations
https://doi.org/10.1016/j.jhep.2022.03.039
J
Joycelyn Jie Xin Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
1.1K
Citations
15
h-index
20
i10-index
Joycelyn Jie Xin Lee is an academic researcher from National University of Singapore. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research. The author has an h-index of 15, co-authored 57 publications.
ORCID: 0000-0002-1070-6125Papers by this author
worksLocoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
2021 · ESMO Open · 13 citations
https://doi.org/10.1016/j.esmoop.2021.100129
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer
2025 · ESMO Open · 3 citations
https://doi.org/10.1016/j.esmoop.2025.105826
The impact of socioeconomic status with overall survival in hepatocellular carcinoma: a systematic review and meta-analysis
2025 · ESMO Gastrointestinal Oncology · 0 citations
https://doi.org/10.1016/j.esmogo.2025.100259
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat